Ateme shares jump 9.5% after strong H1 results

Ateme shares rose 9.5% after reporting robust H1 2025 results, with EBITDA reaching €1.5 million, significantly exceeding analyst expectations (Kepler Cheuvreux forecast -€1.8 million) and marking a €5.8 million improvement year-over-year. Management attributed this performance to effective cost management and expressed confidence in a stronger second half, reaffirming medium-term financial targets of €130 million revenue and €22 million EBITDA.

Analysis

Ateme (ATME) shares demonstrated significant strength, rising 9.5% following the release of its first-half 2025 results which materially surpassed analyst forecasts. The company reported an EBITDA of €1.5 million, a notable outperformance against Kepler Cheuvreux’s projection of a -€1.8 million loss and a substantial €5.8 million improvement from the prior-year period. This positive swing in profitability is attributed to effective cost structure management and optimization, indicating successful execution on operational efficiency. Management has provided a confident outlook for a stronger second half, citing catalysts such as seasonal strength, a recovering US market, and accelerating new client momentum. Furthermore, the company's reaffirmation of its medium-term financial targets—including €130 million in revenue and €22 million in EBITDA—anchors the strong H1 performance within a clear long-term growth and profitability framework.

Key Decisions for Investors

• The significant EBITDA beat and positive guidance suggest a potential re-rating of the stock; investors should consider this a strong bullish signal reflecting improved operational leverage and profitability.
• Monitor upcoming reports for tangible evidence of the US market recovery and new client acquisition momentum, as these are the key drivers cited by management for achieving the stronger second-half forecast.
• Evaluate the credibility of the path to the reaffirmed medium-term targets, as achieving €22 million in EBITDA from the current run-rate represents a substantial execution challenge and a key factor for long-term valuation.
• Given the sharp 9.5% share price increase, investors may consider trimming for risk management, but the fundamental improvement in the company's cost structure could justify holding or adding to positions on any pullbacks.